• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment


84.950 SEK 0.350 0.41%

As of 11:02:17 ET on 04/17/2014.

Snapshot for Elekta AB (EKTAB)

Open: 85.500 Day's Range: 84.550 - 85.550 Volume: 826,239
Previous Close: 85.300 52wk Range: 81.450 - 115.231 1-Yr Rtn: -13.50%

Stock Chart for EKTAB

No chart data available.
  • EKTAB:SS 84.950
  • 1D
  • 1M
  • 1Y
Interactive EKTAB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EKTAB

Current P/E Ratio (ttm) 27.6326
Estimated P/E(04/2014) 23.6695
Relative P/E vs. OMX 1.6293
Earnings Per Share (SEK) (ttm) 3.0743
Est. EPS (SEK) (04/2014) 3.5890
Est. PEG Ratio 2.1567
Market Cap (M SEK) 32,521.29
Shares Outstanding (M) 368.58
30 Day Average Volume 1,597,594
Price/Book (mrq) 6.1148
Price/Sale (ttm) 3.0769
Dividend Indicated Gross Yield 1.77%
Cash Dividend (SEK) 1.5000
Dividend Ex-Date 09/04/2013
5 Year Dividend Growth 35.52%
Next Earnings Announcement 05/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EKTAB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for EKTAB

Elekta AB produces and sells advanced medical products for treatment of neurological disorders and radiation of cancer. The Company has developed the Gamma Knife, a non-invasive surgical tool for the management of small and hard to locate intracranial lesions, as well as a complete system for stereotactic neurosurgery. Elekta markets worldwide.

Laurent LeksellChairman/FounderNiklas SavanderVarious Positions
Tomas PuuseppPresident/CEOHakan BergstromChief Financial Officer
More Company Profile & Key Executives for EKTAB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil